BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
PDX1
,
T cell differentiation
,
Inflammatory disorder
,
Leukocyte
,
Quercetin
,
rs6983267
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Leflunomide
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
CYP1A1
STAC3
CYP1B1
RB1
FOS
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
organic cyclic compound binding
heterocyclic compound binding
regulation of nitrogen compound metabolic process
small molecule binding
anion binding
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Renal clear cell cancer Caki-2 cells after treatment with leflunomide
Livers of rats exposed to 27 agents with different mechanisms of action for toxicity
Embryonic gene expression in zebrafish treated with leflunomide
Livers from rats exposed to chemicals with different mechanisms of action
Livers from wildtype Sprague-Dawley rats exposed to 27 chemicals
Explore Curated Studies Results
Literature
Most Relevant Literature
Leflunomide: dermatologic perspective.
Leflunomide: friend or foe for systemic lupus erythematosus?
Leflunomide in dermatology.
Leflunomide for cytomegalovirus: bench to bedside.
The SMILE study -- safety of methotrexate in combination with leflunomide in rheumatoid arthritis.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Leflunomide in Mild COVID-19 Patients
Leflunomide to Treat Uveitis
Leflunomide for Maintenance of Remission in IgG4 Related Disease
Treatment With Leflunomide in Patients With Polymyalgia Rheumatica
Leflunomide Treatment for IgG4-RD
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ